|
1
|
Qiao WL, Shi BW, Han YD, Tang HM, Lin J,
Hu HY and Lin Q: Testes-specific protease 50 as an independent risk
factor for poor prognosis in patients with non-small cell lung
cancer. Oncol Lett. 15:8796–8804. 2018.PubMed/NCBI
|
|
2
|
Su Q, Sun YP, Liu YH, Li Z, Yang HY, Sun
ZG, Cao BW and Jia JH: Prognostic factors in older patients with
advanced non-small cell lung cancer in China. Tumori. 100:69–74.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen S, Zhang R, Guo Y, Loehrer E, Wei Y,
Zhu Y, Yuan Q, Moran S, Fleischer T, Bjaanaes MM, et al: A
multi-omic study reveals BTG2 as a reliable prognostic marker for
early-stage non-small cell lung cancer. Mol Oncol. 12:913–924.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng X, Cheng M, Fu B, Fan X, Wang Q, Yu
X, Sun R, Tian Z and Wei H: Targeting LUNX inhibits non-small cell
lung cancer growth and metastasis. Cancer Res. 75:1080–1090. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McCarroll JA, Gan PP, Erlich RB, Liu M,
Dwarte T, Sagnella SS, Akerfeldt MC, Yang L, Parker AL, Chang MH,
et al: TUBB3/βIII-tubulin acts through the PTEN/AKT signaling axis
to promote tumorigenesis and anoikis resistance in non-small cell
lung cancer. Cancer Res. 75:415–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yue Y, Liu J and He C: RNA
N6-methyladenosine methylation in post-transcriptional gene
expression regulation. Genes Dev. 29:1343–1355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang BI, Miyauchi K, Matuszewski M,
D'Almeida GS, Rubio MAT, Alfonzo JD, Inoue K, Sakaguchi Y and
Suzuki T, Sochacka E and Suzuki T: Identification of 2-methylthio
cyclic N6-threonylcarbamoyladenosine (ms2ct6A) as a novel RNA
modification at position 37 of tRNAs. Nucleic Acids Res.
45:2124–2136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vaidyanathan PP, AlSadhan I, Merriman DK,
Al-Hashimi HM and Herschlag D: Pseudouridine and
N6-methyladenosine modifications weaken PUF protein/RNA
interactions. RNA. 23:611–618. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao BS and He C: Pseudouridine in a new
era of RNA modifications. Cell Res. 25:153–154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang CY, Lin MH and Su HT: A method for
measuring RNA N 6-methyladenosine modifications in cells and
tissues. J Vis Exp. 5:2016.
|
|
11
|
Yu J, Chen M, Huang H, Zhu J, Song H, Zhu
J, Park J and Ji SJ: Dynamic m6A modification regulates local
translation of mRNA in axons. Nucleic Acids Res. 46:1412–1423.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thiaville PC, El Yacoubi B, Köhrer C,
Thiaville JJ, Deutsch C, Iwata-Reuyl D, Bacusmo JM, Armengaud J,
Bessho Y, Wetzel C, et al: Essentiality of
threonylcarbamoyladenosine (t(6)A), a universal tRNA modification,
in bacteria. Mol Microbiol. 98:1199–1221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
El Yacoubi B, Lyons B, Cruz Y, Reddy R,
Nordin B, Agnelli F, Williamson JR, Schimmel P, Swairjo MA and de
Crécy-Lagard V: The universal YrdC/Sua5 family is required for the
formation of threonylcarbamoyladenosine in tRNA. Nucleic Acids Res.
37:2894–2909. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang B, Zhai W, Hu G, Huang C, Xie T,
Zhang J and Xu Y: MicroRNA-206 acts as a tumor suppressor in
bladder cancer via targeting YRDC. Am J Transl Res. 8:4705–4715.
2016.PubMed/NCBI
|
|
15
|
Cui F, Hu J, Ning S, Tan J and Tang H:
Overexpression of MCM10 promotes cell proliferation and predicts
poor prognosis in prostate cancer. Prostate. 78:1299–1310. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kroiss A, Vincent S, Decaussin-Petrucci M,
Meugnier E, Viallet J, Ruffion A, Chalmel F, Samarut J and Allioli
N: Androgen-regulated microRNA-135a decreases prostate cancer cell
migration and invasion through downregulating ROCK1 and ROCK2.
Oncogene. 34:2846–2855. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu T, An S, Choy MT, Zhou J, Wu S, Liu S,
Liu B, Yao Z, Zhu X, Wu J and He Z: LncRNA DUXAP9-206 directly
binds with Cbl-b to augment EGFR signaling and promotes non-small
cell lung cancer progression. J Cell Mol Med. 23:1852–1864. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sanchez-Palencia A, Gomez-Morales M,
Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R and Fárez-Vidal ME:
Gene expression profiling reveals novel biomarkers in nonsmall cell
lung cancer. Int J Cancer. 129:355–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers
Prev. 19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hou J, Aerts J, den Hamer B, van Ijcken W,
den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens
JA, Hoogsteden HC, et al: Gene expression-based classification of
non-small cell lung carcinomas and survival prediction. PLoS One.
5:e103122010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:(Database Issue). D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bindea G, Mlecnik B, Hackl H, Charoentong
P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z and
Galon J: ClueGO: A Cytoscape plug-in to decipher functionally
grouped gene ontology and pathway annotation networks.
Bioinformatics. 25:1091–1093. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Viktorsson K and Lewensohn R: Apoptotic
signaling pathways in lung cancer. J Thorac Oncol. 2:175–179. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liao M: Some features of lung cancer in
China. Lung Cancer. 10:107–116. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie Y, Zhang Y, Du L, Jiang X, Yan S, Duan
W, Li J, Zhan Y, Wang L, Zhang S, et al: Circulating long noncoding
RNA act as potential novel biomarkers for diagnosis and prognosis
of non-small cell lung cancer. Mol Oncol. 12:648–658. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Serresi M, Gargiulo G, Proost N, Siteur B,
Cesaroni M, Koppens M, Xie H, Sutherland KD, Hulsman D, Citterio E,
et al: Polycomb repressive complex 2 is a barrier to KRAS-Driven
inflammation and epithelial-mesenchymal transition in
non-small-cell lung cancer. Cancer Cell. 29:17–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ludlow AT, Wong MS, Robin JD, Batten K,
Yuan L, Lai TP, Dahlson N, Zhang L, Mender I, Tedone E, et al:
NOVA1 regulates hTERT splicing and cell growth in non-small cell
lung cancer. Nat Commun. 9:31122018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kaczanowska M and Rydén-Aulin M: The YrdC
protein-a putative ribosome maturation factor. Biochim Biophys
Acta. 1727:87–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lemiere S, Azar R, Belloc F, Gürsel D,
Pyronnet S, Bikfalvi A and Auguste P: Overexpression of high
molecular weight FGF-2 forms inhibits glioma growth by acting on
cell-cycle progression and protein translation. Exp Cell Res.
314:3701–3711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brewer JW, Hendershot LM, Sherr CJ and
Diehl JA: Mammalian unfolded protein response inhibits cyclin D1
translation and cell-cycle progression. Proc Natl Acad Sci USA.
96:8505–8510. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakamura H and Nishimura T: History,
molecular features, and clinical importance of conventional serum
biomarkers in lung cancer. Surg Today. 47:1037–1059. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin Q, Chen XY, Liu WF, Zhu PW, Shi WQ, Li
B, Yuan Q, Min YL, Liu JM and Shao Y: Diagnostic value of CA-153
and CYFRA 21-1 in predicting intraocular metastasis in patients
with metastatic lung cancer. Cancer Med. Jun 20–2019.(Epub ahead of
print).
|
|
37
|
Zhang G, Xu Y, Lu X, Huang H, Zhou Y, Lu B
and Zhang X: Diagnosis value of serum B7-H3 expression in non-small
cell lung cancer. Lung Cancer. 66:245–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu Y, Yang A, Hu S, Zhang J and Yan H:
Significance of human papillomavirus 16/18 infection in association
with p53 mutation in lung carcinomas. Clin Respir J. 7:27–33. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Niklinska W, Burzykowski T, Chyczewski L
and Niklinski J: Expression of vascular endothelial growth factor
(VEGF) in non-small cell lung cancer (NSCLC): Association with p53
gene mutation and prognosis. Lung Cancer. 34 (Suppl 2):S59–S64.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li S, Zhao H, Li J, Zhang A and Wang H:
Downregulation of long non-coding RNA LET predicts poor prognosis
and increases Notch signaling in non-small cell lung cancer.
Oncotarget. 9:1156–1168. 2017.PubMed/NCBI
|
|
41
|
Han L, Zhang EB, Yin DD, Kong R, Xu TP,
Chen WM, Xia R, Shu YQ and De W: Low expression of long noncoding
RNA PANDAR predicts a poor prognosis of non-small cell lung cancer
and affects cell apoptosis by regulating Bcl-2. Cell Death Dis.
6:e16652015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He X, Liu Z, Su J, Yang J, Yin D, Han L,
De W and Guo R: Low expression of long noncoding RNA CASC2
indicates a poor prognosis and regulates cell proliferation in
non-small cell lung cancer. Tumour Biol. 37:9503–9510. 2016.
View Article : Google Scholar : PubMed/NCBI
|
